Beijing Strong Biotechnologies proposes new director, schedules extraordinary meeting

Beijing Strong Biotechnologies (SZSE:300406) announced the resolutions of its fifth board of directors' nineteenth meeting held on September 23, 2025. The board approved the nomination of Mr. Wang Yongli as a non-independent director candidate for the fifth board of directors. This follows the resignation of former vice chairman and director Mr. Liang Hongjun due to work relocation. Mr. Wang Yongli's term will run from the date of approval at the extraordinary general meeting until the end of the fifth board of directors' tenure. Mr. Wang, born in April 1980, holds a master's degree and is a certified public accountant. He currently serves as a director, general manager, and deputy secretary of the Party General Branch at China Pharmaceutical Investment Co., Ltd., the company's largest shareholder. He does not hold any company shares.

The board also approved a proposal to convene the 2025 first extraordinary general meeting on October 10, 2025, at 2:00 PM in the company's meeting room in Beijing. The meeting will utilize both on-site voting and online voting via the Shenzhen Stock Exchange trading system and internet voting system. The equity registration date for the meeting is September 29, 2025. The primary agenda item for the general meeting is the election of the non-independent director.